PRAH - PRA Health Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 56.58B
Enterprise Value 37.63B
Trailing P/E 41.90
Forward P/E 117.69
PEG Ratio (5 yr expected) 11.45
Price/Sales (ttm)2.27
Price/Book (mrq)5.93
Enterprise Value/Revenue 32.64
Enterprise Value/EBITDA 617.06

Trading Information

Stock Price History

Beta (3Y Monthly) 1.54
52-Week Change 3-1.86%
S&P500 52-Week Change 36.80%
52 Week High 3121.98
52 Week Low 382.12
50-Day Moving Average 395.96
200-Day Moving Average 399.66

Share Statistics

Avg Vol (3 month) 3599.42k
Avg Vol (10 day) 3359.56k
Shares Outstanding 565.66M
Float 58.89M
% Held by Insiders 10.11%
% Held by Institutions 1103.37%
Shares Short (Jun 28, 2019) 41.9M
Short Ratio (Jun 28, 2019) 42.93
Short % of Float (Jun 28, 2019) 43.23%
Short % of Shares Outstanding (Jun 28, 2019) 42.90%
Shares Short (prior month May 31, 2019) 41.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 5.50%
Operating Margin (ttm)11.58%

Management Effectiveness

Return on Assets (ttm)6.23%
Return on Equity (ttm)15.48%

Income Statement

Revenue (ttm)2.89B
Revenue Per Share (ttm)44.81
Quarterly Revenue Growth (yoy)2.90%
Gross Profit (ttm)1.37B
EBITDA 447.45M
Net Income Avi to Common (ttm)159.01M
Diluted EPS (ttm)2.39
Quarterly Earnings Growth (yoy)13.10%

Balance Sheet

Total Cash (mrq)177.14M
Total Cash Per Share (mrq)2.7
Total Debt (mrq)1.28B
Total Debt/Equity (mrq)115.13
Current Ratio (mrq)0.90
Book Value Per Share (mrq)16.89

Cash Flow Statement

Operating Cash Flow (ttm)336.2M
Levered Free Cash Flow (ttm)336.61M